P

Pulmatrix
D

PULM

8.81000
USD
-0.29
(-3.19%)
مغلق
حجم التداول
550
الربح لكل سهم
-5
العائد الربحي
-
P/E
-3
حجم السوق
32,176,631
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AGEN
    -0.11500
    (-3.34%)
    3.33000 USD
    B
    BCRX
    -0.17000
    (-1.81%)
    9.20000 USD
    C
    CRBP
    -0.09000
    (-1.09%)
    8.20000 USD
    D
    DVAX
    0.000
    (0.00%)
    13.335 USD
    M
    MNOV
    0.07000
    (3.98%)
    1.83000 USD
    T
    TGTX
    -0.040
    (-0.13%)
    30.900 USD
    V
    VKTX
    2.480
    (7.85%)
    34.090 USD
    X
    XENE
    0.410
    (1.04%)
    39.690 USD
    المزيد
الأخبار
المقالات

العنوان: Pulmatrix

القطاع: Healthcare
الصناعة: Biotechnology
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmetmedical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.